MUX Fundamental Analysis - MCEWEN INC

Fundamental Rating

MUX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 157 industry peers in the Metals & Mining industry. MUX may be in some trouble as it scores bad on both profitability and health. MUX is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MUX has reported negative net income.

In the past year MUX had a positive cash flow from operations.

In the past 5 years MUX reported 4 times negative net income.

In the past 5 years MUX reported 4 times negative operating cash flow.

1.2 Ratios

MUX has a Return On Assets (-1.59%) which is comparable to the rest of the industry.

The Return On Equity of MUX (-2.44%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-1.59%
ROE	-2.44%
ROIC	N/A

ROA(3y)-4.5%

ROA(5y)-10.95%

ROE(3y)-7.65%

ROE(5y)-15.95%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MUX has a Gross Margin of 18.34%. This is comparable to the rest of the industry: MUX outperforms 54.14% of its industry peers.

In the last couple of years the Gross Margin of MUX has grown nicely.

MUX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	18.34%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y18.18%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, MUX has more shares outstanding

The number of shares outstanding for MUX has been increased compared to 5 years ago.

Compared to 1 year ago, MUX has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.54, we must say that MUX is in the distress zone and has some risk of bankruptcy.

MUX has a Altman-Z score of 0.54. This is amonst the worse of the industry: MUX underperforms 84.08% of its industry peers.

A Debt/Equity ratio of 0.26 indicates that MUX is not too dependend on debt financing.

MUX's Debt to Equity ratio of 0.26 is in line compared to the rest of the industry. MUX outperforms 41.40% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.26
Debt/FCF	N/A
Altman-Z	0.54

ROIC/WACCN/A

WACC9.29%

2.3 Liquidity

A Current Ratio of 2.10 indicates that MUX has no problem at all paying its short term obligations.

With a Current ratio value of 2.10, MUX perfoms like the industry average, outperforming 42.68% of the companies in the same industry.

A Quick Ratio of 1.58 indicates that MUX should not have too much problems paying its short term obligations.

MUX has a Quick ratio of 1.58. This is comparable to the rest of the industry: MUX outperforms 53.50% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.1
Quick Ratio	1.58

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.80% over the past year.

Looking at the last year, MUX shows a very negative growth in Revenue. The Revenue has decreased by -16.62% in the last year.

Measured over the past years, MUX shows a quite strong growth in Revenue. The Revenue has been growing by 8.32% on average per year.

EPS 1Y (TTM)61.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%75%

Revenue 1Y (TTM)-16.62%

Revenue growth 3Y8.53%

Revenue growth 5Y8.32%

Sales Q2Q%-3.28%

3.2 Future

The Earnings Per Share is expected to grow by 113.90% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 11.41% on average over the next years. This is quite good.

EPS Next Y99.46%

EPS Next 2Y107.88%

EPS Next 3Y113.9%

EPS Next 5YN/A

Revenue Next Year-11.15%

Revenue Next 2Y13.05%

Revenue Next 3Y11.41%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MUX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 15.13, which indicates a correct valuation of MUX.

70.06% of the companies in the same industry are more expensive than MUX, based on the Price/Forward Earnings ratio.

When comparing the Price/Forward Earnings ratio of MUX to the average of the S&P500 Index (24.04), we can say MUX is valued slightly cheaper.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	15.13

4.2 Price Multiples

MUX's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	102.78

4.3 Compensation for Growth

MUX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

MUX's earnings are expected to grow with 113.90% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y107.88%

EPS Next 3Y113.9%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MUX!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

MCEWEN INC

NYSE:MUX (1/13/2026, 7:30:03 PM)

After market: 22.34 +0.56 (+2.57%)

21.78

-0.02 (-0.09%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)11-05 2025-11-05/amc

Earnings (Next)03-12 2026-03-12/bmo

Inst Owners45.87%

Inst Owner Change0%

Ins Owners0.6%

Ins Owner Change0.8%

Market Cap1.19B

Revenue(TTM)166.45M

Net Income(TTM)-11.92M

Analysts80

Price Target23.05 (5.83%)

Short Float %19.84%

Short Ratio6.85

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)193.94%

Min EPS beat(2)-106.19%

Max EPS beat(2)494.06%

EPS beat(4)1

Avg EPS beat(4)46.88%

Min EPS beat(4)-197.03%

Max EPS beat(4)494.06%

EPS beat(8)3

Avg EPS beat(8)8.28%

EPS beat(12)5

Avg EPS beat(12)-40.66%

EPS beat(16)6

Avg EPS beat(16)-62.37%

Revenue beat(2)0

Avg Revenue beat(2)-13.91%

Min Revenue beat(2)-22.09%

Max Revenue beat(2)-5.74%

Revenue beat(4)1

Avg Revenue beat(4)-8.56%

Min Revenue beat(4)-22.09%

Max Revenue beat(4)3.09%

Revenue beat(8)5

Avg Revenue beat(8)-1.07%

Revenue beat(12)6

Avg Revenue beat(12)-3.06%

Revenue beat(16)6

Avg Revenue beat(16)-5.73%

PT rev (1m)1.8%

PT rev (3m)45.81%

EPS NQ rev (1m)15.38%

EPS NQ rev (3m)80%

EPS NY rev (1m)83.35%

EPS NY rev (3m)-102.72%

Revenue NQ rev (1m)-10.03%

Revenue NQ rev (3m)7.57%

Revenue NY rev (1m)-4.22%

Revenue NY rev (3m)5.34%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	15.13
P/S	7.13
P/FCF	N/A
P/OCF	465.51
P/B	2.43
P/tB	2.43
EV/EBITDA	102.78

EPS(TTM)-0.34

EYN/A

EPS(NY)1.44

Fwd EY6.61%

FCF(TTM)-0.87

FCFYN/A

OCF(TTM)0.05

OCFY0.21%

SpS3.06

BVpS8.97

TBVpS8.97

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.59%
ROE	-2.44%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	18.34%
FCFM	N/A

ROA(3y)-4.5%

ROA(5y)-10.95%

ROE(3y)-7.65%

ROE(5y)-15.95%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y18.18%

F-Score4

Asset Turnover0.22

Health

		Industry Rank	Sector Rank
Debt/Equity	0.26
Debt/FCF	N/A
Debt/EBITDA	10.66
Cap/Depr	181.37%
Cap/Sales	29.99%
Interest Coverage	N/A
Cash Conversion	21.58%
Profit Quality	N/A
Current Ratio	2.1
Quick Ratio	1.58
Altman-Z	0.54

F-Score4

WACC9.29%

ROIC/WACCN/A

Cap/Depr(3y)153.99%

Cap/Depr(5y)131.29%

Cap/Sales(3y)27.62%

Cap/Sales(5y)24.24%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)61.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%75%

EPS Next Y99.46%

EPS Next 2Y107.88%

EPS Next 3Y113.9%

EPS Next 5YN/A

Revenue 1Y (TTM)-16.62%

Revenue growth 3Y8.53%

Revenue growth 5Y8.32%

Sales Q2Q%-3.28%

Revenue Next Year-11.15%

Revenue Next 2Y13.05%

Revenue Next 3Y11.41%

Revenue Next 5YN/A

EBIT growth 1Y-1953.46%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year254.49%

EBIT Next 3Y101.59%

EBIT Next 5YN/A

FCF growth 1Y57.43%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y104.9%

OCF growth 3YN/A

OCF growth 5YN/A

MCEWEN INC / MUX FAQ

What is the ChartMill fundamental rating of MCEWEN INC (MUX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MUX.

What is the valuation status of MCEWEN INC (MUX) stock?

ChartMill assigns a valuation rating of 4 / 10 to MCEWEN INC (MUX). This can be considered as Fairly Valued.

What is the profitability of MUX stock?

MCEWEN INC (MUX) has a profitability rating of 2 / 10.

What is the financial health of MCEWEN INC (MUX) stock?

The financial health rating of MCEWEN INC (MUX) is 3 / 10.

MCEWEN INC (MUX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MCEWEN INC / MUX FAQ

What is the ChartMill fundamental rating of MCEWEN INC (MUX) stock?

What is the valuation status of MCEWEN INC (MUX) stock?

What is the profitability of MUX stock?

What is the financial health of MCEWEN INC (MUX) stock?